Gara Jalqabaatti › Dermatitis Atopic (Eczema) › Alabama › Birmingham
Qorannoo klinikaalii Dermatitis Atopic (Eczema) Birmingham, AL keessatti
Qorannoo 9 Dermatitis Atopic (Eczema) f Birmingham fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.
Takkalaa qorannoo (Ingiliffa)
Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →
This Study is a Non-interventional Disease Registry of Adolescent and Adult Patients With Atopic Dermatitis Who Initiate or Switch Any Systemic Treatment
Namoota walitti qabaa jiraQorannoo ilaalaa
- Cahaba Dermatology & Skin Health Center- Site Number : 8400006, Birmingham
Platform Study to Evaluate the Efficacy and Safety of Investigational Compound(s) in Patients With Moderate to Severe Atopic Dermatitis
Namoota walitti qabaa jiraSadarkaa 2
- Novartis Investigative Site, Birmingham
- Novartis Investigative Site, Birmingham
A Long-term Study of the Medicine Called Abrocitinib in Children Aged 2 Years and Older With Moderate to Severe Eczema
Namoota walitti qabaa jiraSadarkaa 3
- Cahaba Dermatology & Skin Health Center, Birmingham
Study of ENV-294 in Adults With Moderate-to-Severe Atopic Dermatitis
Namoota walitti qabaa jiraSadarkaa 2
- Enveda Investigative Site, Birmingham
First-in-Human Trial to Assess REGN20423 in Healthy Adult Participants and Adult Participants With Atopic Dermatitis
Namoota walitti qabaa jiraSadarkaa 1Hojjettoota fayyaa simatamoo
- Cahaba Dermatology & Skin Health Center, LLC, Birmingham
A Phase 2b Study of the Effects of Camoteskimab in Adults With Moderate-to-Severe Atopic Dermatitis
Namoota walitti qabaa jiraSadarkaa 2
- AllerVie Clinical Research, Birmingham
- Cahaba Dermatology and Skin Health Center, Birmingham
A Trial to Evaluate the Efficacy and Safety of Tralokinumab in Combination With Topical Corticosteroids in Children and Infants With Moderate-to-severe Atopic Dermatitis
Namoota walitti qabaa jiraSadarkaa 3
- Leo Pharma Investigational site, Birmingham
A Study of Upadacitinib in Adult Participants With Moderate-to-Severe Atopic Dermatitis and Inadequate Response to Dupilumab
Namoota walitti qabaa jiraSadarkaa 3
- Cahaba Dermatology & Skin Health Center /ID# 263855, Birmingham
A Study To Learn About Two Study Medicines (PF-07275315 And PF-07264660) In People Who Have Moderate To Severe Atopic Dermatitis
Namoota walitti qabaa jiraSadarkaa 2
- Allervie Clinical Research, Birmingham
Qorannoo Dermatitis Atopic (Eczema) magaalota biroo keessatti
- New York City, NYQorannoo 13
- Los Angeles, CAQorannoo 11
- Washington, DCQorannoo 11
- San Antonio, TXQorannoo 10
- San Diego, CAQorannoo 10
- Miami, FLQorannoo 9
- Dallas, TXQorannoo 8
- Huntington Beach, CAQorannoo 8
- Sacramento, CAQorannoo 8
- Troy, MIQorannoo 8
- Indianapolis, INQorannoo 7
- Pittsburgh, PAQorannoo 7
Qorannoo biroo Birmingham keessatti
- Saree (Gosoota Hunda)Qorannoo 31
- Saree OljooQorannoo 24
- Kansarii OvariiQorannoo 23
- ObesityQorannoo 23
- Kansara Qara'a Non-Small CellQorannoo 22
- Leukemia Myeloidii HamaaQorannoo 21
- Myeloma Baay’eeQorannoo 18
- COPDQorannoo 17
- Dhibee Onneessaa fi DhiigaQorannoo 17
- Sukkaraa Gosa 2Qorannoo 16
- Kansa EndometiriyaaliiQorannoo 16
- Baayyee UlfaataaQorannoo 16
Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.